Startup profile for Patch Biosciences: what they do, why they are interesting, stage (acquired), industries, and links to our funding articles. Part of the Venture Capital Tracker startup directory.
Venture Capital Tracker Logo

Venture Capital Tracker

Startup profile · funding coverage

Patch Biosciences

Patch Biosciences developed programmable DNA medicines before the biotech wound down or was acquired.

Stage

acquired

Status

acquired

Coverage

full

Why Patch Biosciences is interesting

A synthetic-biology play in the a16z bio portfolio targeting programmable therapeutics — early-stage platform for gene-level drug design.

Key facts

  • a16z portfolio status: Exit
  • Co-investors: no additional institutional investors disclosed in public sources reviewed 2026-07-24

Investors in our directory

Funds linked from Patch Biosciences's profile — open a fund page for stage focus and related deal articles.

Andreessen Horowitz

Industries

Generalist Technology

Industry hub pages are rolling out from our fund-derived baseline taxonomy.

Related funding articles

Venture Capital Tracker pieces that cover Patch Biosciences's financing or category context.

All startups Funding news

Last updated: 2026-07-24